Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers

Aims: The purpose of this study was to detect potential cytokines markers involved in the Graves’ orbitopathy (GO). Materials and Methods: We measured 25 plasma cytokines using label-free quantitative proteomic analysis in the pilot cohort. In validation cohort, NORCH3, TBP, α-enolase (ENO1), GPX3,...

Full description

Saved in:
Bibliographic Details
Main Authors: Ying Fu, Yuanyuan Zhang, Yaxin An, Bin Cao, Dong Zhao
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-04-01
Series:Environmental Disease
Subjects:
Online Access:https://journals.lww.com/10.4103/ed.ed_3_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590691864150016
author Ying Fu
Yuanyuan Zhang
Yaxin An
Bin Cao
Dong Zhao
author_facet Ying Fu
Yuanyuan Zhang
Yaxin An
Bin Cao
Dong Zhao
author_sort Ying Fu
collection DOAJ
description Aims: The purpose of this study was to detect potential cytokines markers involved in the Graves’ orbitopathy (GO). Materials and Methods: We measured 25 plasma cytokines using label-free quantitative proteomic analysis in the pilot cohort. In validation cohort, NORCH3, TBP, α-enolase (ENO1), GPX3, ORM1, extracellular matrix protein-1 (ECM1), SERPINE, IGF1, IGKV1, and SPARC were validated using ELISA kits. We used label-free liquid chromatography–mass spectrometry/MS (LC–MS/MS) quantitative proteomic to analyze plasma cytokines content of Graves’ disease and GO patients. Results: The validation cohort showed that the concentrations of ECM1, ENO1, and GPX3, (244.4276 pg/ml, 4.361807 ng/ml, and 17.72794 pmol/ml, respectively) were significantly lower in GO patients samples than those in Graves’ patients (257.3197 pg/ml, 4.601592 ng/ml, and 21.33118 pmol/ml, respectively). Both univariate and multivariate logistic analyses indicated that GPX3, ECM1, and ENO might be predictors of Graves’ ophthalmopathy. A receiver-operating characteristic curve with an area under the curve of 0.938, a sensitivity of 84.4%, and a specificity of 90.5% underscored the applicability of this method. Conclusions: ECM1, ENO1, and GPX3 were associated with the presence of the GO group and may be good biomarkers that play an important role in the pathogenesis of GO.
format Article
id doaj-art-c5637d304a3a401abd0d5914e37cdd91
institution Kabale University
issn 2468-5704
language English
publishDate 2024-04-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Environmental Disease
spelling doaj-art-c5637d304a3a401abd0d5914e37cdd912025-01-23T09:09:46ZengWolters Kluwer Medknow PublicationsEnvironmental Disease2468-57042024-04-0192465210.4103/ed.ed_3_24Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markersYing FuYuanyuan ZhangYaxin AnBin CaoDong ZhaoAims: The purpose of this study was to detect potential cytokines markers involved in the Graves’ orbitopathy (GO). Materials and Methods: We measured 25 plasma cytokines using label-free quantitative proteomic analysis in the pilot cohort. In validation cohort, NORCH3, TBP, α-enolase (ENO1), GPX3, ORM1, extracellular matrix protein-1 (ECM1), SERPINE, IGF1, IGKV1, and SPARC were validated using ELISA kits. We used label-free liquid chromatography–mass spectrometry/MS (LC–MS/MS) quantitative proteomic to analyze plasma cytokines content of Graves’ disease and GO patients. Results: The validation cohort showed that the concentrations of ECM1, ENO1, and GPX3, (244.4276 pg/ml, 4.361807 ng/ml, and 17.72794 pmol/ml, respectively) were significantly lower in GO patients samples than those in Graves’ patients (257.3197 pg/ml, 4.601592 ng/ml, and 21.33118 pmol/ml, respectively). Both univariate and multivariate logistic analyses indicated that GPX3, ECM1, and ENO might be predictors of Graves’ ophthalmopathy. A receiver-operating characteristic curve with an area under the curve of 0.938, a sensitivity of 84.4%, and a specificity of 90.5% underscored the applicability of this method. Conclusions: ECM1, ENO1, and GPX3 were associated with the presence of the GO group and may be good biomarkers that play an important role in the pathogenesis of GO.https://journals.lww.com/10.4103/ed.ed_3_24graves’ orbitopathylabel-free liquid chromatography–mass spectrometry/mass spectrometryplasma proteinpotential markers
spellingShingle Ying Fu
Yuanyuan Zhang
Yaxin An
Bin Cao
Dong Zhao
Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
Environmental Disease
graves’ orbitopathy
label-free liquid chromatography–mass spectrometry/mass spectrometry
plasma protein
potential markers
title Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
title_full Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
title_fullStr Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
title_full_unstemmed Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
title_short Changes of plasma cytokines content in Graves’ orbitopathy patients, could be potential markers
title_sort changes of plasma cytokines content in graves orbitopathy patients could be potential markers
topic graves’ orbitopathy
label-free liquid chromatography–mass spectrometry/mass spectrometry
plasma protein
potential markers
url https://journals.lww.com/10.4103/ed.ed_3_24
work_keys_str_mv AT yingfu changesofplasmacytokinescontentingravesorbitopathypatientscouldbepotentialmarkers
AT yuanyuanzhang changesofplasmacytokinescontentingravesorbitopathypatientscouldbepotentialmarkers
AT yaxinan changesofplasmacytokinescontentingravesorbitopathypatientscouldbepotentialmarkers
AT bincao changesofplasmacytokinescontentingravesorbitopathypatientscouldbepotentialmarkers
AT dongzhao changesofplasmacytokinescontentingravesorbitopathypatientscouldbepotentialmarkers